Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry" [Eur. J. Cancer 212, 2024, 115056].
Özkan A, Kapiteijn E, van den Bos F, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Bloem M, Blokx WAM, Boers-Sonderen MJ, Bonenkamp JJ, van den Eertwegh AJM, de Groot JWB, Haanen JB, Holtslag CE, Hospers GAP, Piersma D, van Rijn RS, Stevense-den Boer AM, Suijkerbuijk KPM, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Portielje JEA, de Glas NA. Özkan A, et al. Among authors: de glas na. Eur J Cancer. 2024 Dec 26;216:115194. doi: 10.1016/j.ejca.2024.115194. Online ahead of print. Eur J Cancer. 2024. PMID: 39732138 No abstract available.
Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.
Tran Van Hoi E, Santegoets SJ, Mooijaart SP, Van Heemst D, Özkan A, Verdegaal EME, Slingerland M, Kapiteijn E, van der Burg SH, Portielje JEA, Welters MJP, de Glas NA. Tran Van Hoi E, et al. Among authors: de glas na. Immun Ageing. 2024 Nov 27;21(1):83. doi: 10.1186/s12979-024-00463-y. Immun Ageing. 2024. PMID: 39593063 Free PMC article.
Association of Glasgow Prognostic Score with frailty, mortality and adverse health outcomes in older patients with cancer: A prospective cohort study.
van Holstein Y, Trompet S, van Munster BC, van den Berkmortel PJE, van Heemst D, de Glas NA, Slingerland M, Slagboom PE, Holterhues C, Labots G, Mooijaart SP, Portielje JEA, van den Bos F. van Holstein Y, et al. Among authors: de glas na. J Geriatr Oncol. 2024 Nov;15(8):102075. doi: 10.1016/j.jgo.2024.102075. Epub 2024 Oct 16. J Geriatr Oncol. 2024. PMID: 39414486 Free article.
Adjuvant immunotherapy in older patients with stage III and resected stage IV melanoma: Toxicity and recurrence-free survival outcomes from the Dutch melanoma treatment registry.
Özkan A, Kapiteijn E, van den Bos F, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Bloem M, Blokx WAM, Boers-Sonderen MJ, Bonenkamp JJ, van den Eertwegh AJM, de Groot JWB, Haanen JB, Holtslag CE, Hospers GAP, Piersma D, van Rijn RS, Stevense-den Boer AM, Suijkerbuijk KPM, van der Veldt AAM, Vreugdenhil G, Wouters MWJM, Portielje JEA, de Glas NA. Özkan A, et al. Among authors: de glas na. Eur J Cancer. 2024 Nov;212:115056. doi: 10.1016/j.ejca.2024.115056. Epub 2024 Sep 30. Eur J Cancer. 2024. PMID: 39368226 Free article.
DOSAGE study: protocol for a phase III non-inferiority randomised trial investigating dose-reduced chemotherapy for advanced colorectal cancer in older patients.
Baltussen JC, van den Bos F, Slingerland M, Binda TRR, Liefers GJ, van den Hout WB, Fiocco M, Verschoor AJ, Cloos-van Balen M, Holterhues C, Houtsma D, Jochems A, Spierings LEAMM, van Bodegom-Vos L, Mooijaart SP, Gelderblom H, Speetjens FM, de Glas NA, Portielje JEA. Baltussen JC, et al. Among authors: de glas na. BMJ Open. 2024 Aug 13;14(8):e089882. doi: 10.1136/bmjopen-2024-089882. BMJ Open. 2024. PMID: 39142680 Free PMC article.
The performance of metabolomics-based prediction scores for mortality in older patients with solid tumors.
van Holstein Y, Mooijaart SP, van Oevelen M, van Deudekom FJ, Vojinovic D, Bizzarri D, van den Akker EB, Noordam R, Deelen J, van Heemst D, de Glas NA, Holterhues C, Labots G, van den Bos F, Beekman M, Slagboom PE, van Munster BC, Portielje JEA, Trompet S. van Holstein Y, et al. Among authors: de glas na. Geroscience. 2024 Dec;46(6):5615-5627. doi: 10.1007/s11357-024-01261-6. Epub 2024 Jul 4. Geroscience. 2024. PMID: 38963649 Free PMC article.
Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study.
Tran Van Hoi E, Trompet S, Van Holstein Y, Van Den Bos F, Van Heemst D, Codrington H, Labots G, Lohman S, Ozkan A, Portielje J, Mooijaart SP, De Glas NA, Derks M. Tran Van Hoi E, et al. Among authors: de glas na. Drugs Aging. 2024 May;41(5):431-441. doi: 10.1007/s40266-024-01114-z. Epub 2024 May 10. Drugs Aging. 2024. PMID: 38727992 Free PMC article.
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer.
Baltussen JC, Mooijaart SP, Vulink AJE, Houtsma D, Van der Deure WM, Westerman EM, Oosterkamp HM, Spierings LEAMM, van den Bos F, de Glas NA, Portielje JEA. Baltussen JC, et al. Among authors: de glas na. Breast Cancer Res Treat. 2024 Jul;206(2):337-346. doi: 10.1007/s10549-024-07312-y. Epub 2024 Apr 16. Breast Cancer Res Treat. 2024. PMID: 38627318 Free PMC article.
76 results